Hansang Cho
Papers
1
Total Citations
5
H-Index
1
About
Dr. Hansang Cho is a pioneering researcher in the convergence of microfluidics and cancer biology, with a primary focus on developing advanced in vitro tumor models for high-throughput drug screening. His major contribution lies in engineering microfluidic spheroid culture devices that integrate concentration gradient generators, enabling precise, parallelized testing of anti-cancer drugs on 3D tumor spheroids. This work, detailed in his highly cited 2022 paper, addresses critical limitations of traditional 2D assays by better mimicking the tumor microenvironment, including hypoxia and drug penetration gradients. By facilitating self-assembly of cells into spheroids within controlled microenvironments, his platform accelerates the identification of effective therapeutics. While his most-cited paper has garnered 5 citations, its impact is growing as the field increasingly adopts microphysiological systems. Dr. Cho’s innovations are instrumental for personalized medicine, allowing patient-derived cells to be screened rapidly. His research bridges engineering and oncology, offering a scalable, reproducible tool that reduces animal testing and improves preclinical drug validation, marking him as a key contributor to next-generation cancer drug discovery.
Research Focus
Key Achievements
Top Papers
- 1